Phase 2 Vitiligo Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must agree to and sign a consent form before the trial begins.
- You must be between 18 and 75 years old (inclusive) on the day you sign the consent form — both men and women may apply.
- You and your partner must agree not to try to have children during the study and for one month after finishing the medication, not to donate sperm or eggs, and to use effective birth control throughout; women must have a negative pregnancy test and must not be breastfeeding.
- You must have been diagnosed with non-segmental vitiligo during the screening process.
- You must agree to stop using all vitiligo treatments and any cosmetic products with therapeutic effects for the entire duration of the study.
Who may not be able to join:
- People diagnosed with segmental, mixed, or undifferentiated vitiligo, or who have been diagnosed with any other skin pigmentation disorder.
- People whose vitiligo patches on the face cover more than one-third of an area where the hair has also turned white.
- People who have other active skin problems or skin infections during screening that could interfere with the treatment or results.
- People with a history of certain infections or contagious/communicable diseases (confirm with trial site).
- People with a known or suspected history of a weakened immune system.
- People with tuberculosis (TB) or a latent (inactive) TB infection.
- People who test positive for HIV, syphilis, hepatitis C, or hepatitis B.
- People who currently have or have previously had any form of cancer.
- People with abnormal thyroid function, a history of blood clot-related disease in the past 12 months, or a heart or stroke-related event requiring hospitalisation in the past 12 months.
- People with serious problems affecting the heart, mind, kidneys, liver, immune system, digestive system, urinary system, nervous system, muscles and bones, skin, senses, hormones, or blood.
- Women who are pregnant, breastfeeding, or planning to become pregnant during the study.
- People who are known to be allergic to the study drug or any of its ingredients.
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-0518-82342973
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The percentage change in the facial vitiligo area score index (F-VASI) from the baseline.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.